Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 151-156

  Meguro, Shu ^a   Takei, Izumi ^a   Murata, Mitsuru ^a   Hirose, Hiroshi ^a   Takei, Naoyuki ^a   Mitsuyoshi, Yasutaka ^a   Ishii, Keiko ^a   Oguchi, Shuji ^a   Shinohara, Junko ^a   Takeshita, Eiko ^a   Watanabe, Kiyoaki ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAQ POLYMERASE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; REGRESSION ANALYSIS; VASCULAR DISEASE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCOPROTEINS; HUMANS; JAPAN; LIPOPROTEINS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC);

EID: 0035021501     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00606-7     Document Type: Article

References (32)

1. Pyorala K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes. Metab. Rev. 3:1987;463-524.
2. Laakso M., Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Reviews. 5:1997;294-315.
3. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [see comments]. New Engl. J. Med. 339:1998;229-234.
4. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 48:1999;937-942.
5. Lehto S., Ronnemaa T., Haffner S.M., Pyorala K., Kallio V., Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 46:1997;1354-1359.
6. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75:1995;473-486.
7. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes. 46:(Suppl 2):1997;S19-S25.
8. Hesler C.B., Tall A.R., Swenson T.L., Weech P.K., Marcel Y.L., Milne R.W. Monoclonal antibodies to the Mr 74 000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263:1988;5020-5023.
9. Yen F.T., Deckelbaum R.J., Mann C.J., Marcel Y.L., Milne R.W., Tall A.R. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J. Clin. Invest. 83:1989;2018-2024.
10. Tall A.R. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34:1993;1255-1274.
11. Tall A.R. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86:1990;379-384.
12. Hannuksela M.L., Liinamaa M.J., Kesaniemi Y.A., Savolainen M.J. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 110:1994;35-44.
13. Kuivenhoven J.A., de K.P., Boer J.M., Smalheer H.A., Botma G.J., Seidell J.C., Kastelein J.J., Pritchard P.H. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 17:1997;560-568.
14. Kinoshita M., Teramoto T., Shimazu N., Kaneko K., Ohta M., Koike T., Hosogaya S., Ozaki Y., Kume S., Yamanaka M. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. Atherosclerosis. 120:1996;75-82.
15. Bhatnagar D., Durrington P.N., Channon K.M., Prais H., Mackness M.I. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 98:1993;25-32.
16. Foger B., Luef G., Ritsch A., Schmidauer C., Doblinger A., Lechleitner M., Aichner F., Patsch J.R. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J. Mol. Med. 73:1995;369-372.
17. Freeman D.J., Griffin B.A., Holmes A.P., Lindsay G.M., Gaffney D., Packard C.J., Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 14:1994;336-344.
18. Tamminen M., Kakko S., Kesaniemi Y.A., Savolainen M.J. A polymorphic site in the 3′ untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis. 124:1996;237-247.
19. Bu X., Warden C.H., Xia Y.R., De M.C., Puppione D.L., Teruya S., Lokensgard B., Daneshmand S., Brown J., Gray R.J., et al. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum. Genet. 93:1994;639-648.
20. Hill S.A., McQueen M.J. Reverse cholesterol transport - a review of the process and its clinical implications. Clin. Biochem. 30:1997;517-525.
21. Bernard S., Moulin P., Lagrost L., Picard S., Elchebly M., Ponsin G., Chapuis F., Berthezene F. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J. Lipid. Res. 39:1998;59-65.
22. Ukkola O., Savolainen M.J., Salmela P.I., von D.K., Kesaniemi Y.A. DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin. Genet. 46:1994;217-227.
23. Kuivenhoven J.A., Jukema J.W., Zwinderman A.H., de K.P., McPherson R., Bruschke A.V., Lie K.I., Kastelein J.J. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group [see comments]. New Engl. J. Med. 338:1998;86-393.
24. Durlach A., Clavel C., Girard-Globa A., Durlach V. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J. Endocrinol. Metab. 84:1999;3656-3659.
25. World Health Organization; Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org, 1985 (Tech. Rep. Ser, no 727).
26. Ono Y., Aoki S., Ohnishi K., Yasuda T., Kawano K., Tsukada Y. Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res. Clin. Pract. 41:1998;131-137.
27. Zhong S., Sharp D.S., Grove J.S., Bruce C., Yano K., Curb J.D., Tall A.R. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels [see comments]. J. Clin. Invest. 97:1996;2917-2923.
28. Talmud P.J., Edwards K.L., Turner C.M., Newman B., Palmen J.M., Humphries S.E., Austin M.A. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter [in process citation]. Circulation. 101:2000;2461-2466.
29. Burchfiel C.M., Curb J.D., Rodriguez B.L., Yano K., Hwang L.J., Fong K.O., Marcus E.B. Incidence and predictors of diabetes in Japanese-American men: the Honolulu Heart Program. Ann. Epidemiol. 5:1995;33-43.
30. Davies M.J. Stability and instability: two faces of coronary atherosclerosis: the Paul Dudley White Lecture 1995. Circulation. 94:1996;2013-2020.
31. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
32. Watanabe T., Haraoka S., Shimokama T. Inflammatory and immunological nature of atherosclerosis. Int. J. Cardiol. 54:1996;S51-S60. suppl.